Analogously, NRF2 knockdown reduced angiogenesis, concordant with tumor growth reduction, in xenograft models [39], while NRF2 activation in lung cancer stabilized BACH1 by inducing heme oxygenase 1 (HO1) [55]. The gene discussed is NFE2L2; the disease is lung carcinoma.